45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published: assessment threshold met
○Gross / standard charges: below assessment threshold
●Discounted cash price: assessment threshold met
●Payer-specific negotiated rates: assessment threshold met
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
6,287
Insurances with rates
13
CPT / HCPCS codes
4,220
Most expensive procedures (gross)
J9347
$170,526
Tremelimumab-Actl 300 Mg/15 Ml
Gross
$175,800
J9347
$170,526
Tremelimumab-Actl 300 Mg/15 Ml
Gross
$175,800
J2350
$86,355
Ocrelizumab 300 Mg/10 Ml
Gross
$89,025
J2350
$86,355
Ocrelizumab 300 Mg/10 Ml
Gross
$89,025
J9309
$79,164
Polatuzumab Ved-Piiq 140 Mg Vl
Gross
$81,611
J9309
$79,164
Polatuzumab Ved-Piiq 140 Mg Vl
Gross
$81,611
J9026
$65,621
Tarlatamab-DLLE 10 Mg Vial
Gross
$67,650
J9026
$65,621
Tarlatamab-DLLE 10 Mg Vial
Gross
$67,650
J9298
$64,653
Nivolum/Relatlim 240-80Mg 113G
Gross
$66,652
J9298
$64,653
Nivolum/Relatlim 240-80Mg 113G
Gross
$66,652
J9043
$61,756
Cabazitaxel 60 MG/1.5 ML Vial
Gross
$63,665
J9043
$61,756
Cabazitaxel 60 MG/1.5 ML Vial
Gross
$63,665
J9316
$57,775
Pertuzu-Trastuzu 15 Ml Vial
Gross
$59,562
J9316
$57,775
Pertuzu-Trastuzu 15 Ml Vial
Gross
$59,562
J9272
$51,513
Dostarlimab-Gxly 500 Mg/10 Ml
Gross
$53,106
J9272
$51,513
Dostarlimab-Gxly 500 Mg/10 Ml
Gross
$53,106
J9042
$51,399
Brentuximab Vedotin 50 MG Vial
Gross
$52,989
J9042
$51,399
Brentuximab Vedotin 50 MG Vial
Gross
$52,989
J9022
$47,562
Atezolizumab 1200 Mg/20 Ml Vl
Gross
$49,033
J9022
$47,562
Atezolizumab 1200 Mg/20 Ml Vl
Gross
$49,033
J9119
$45,241
Cemiplimab-Rwlc 350 Mg/7 Ml Vl
Gross
$46,640
J9119
$45,241
Cemiplimab-Rwlc 350 Mg/7 Ml Vl
Gross
$46,640
J9144
$43,942
Daratumumab Hyaluronida 1800Mg
Gross
$45,300
J9144
$43,942
Daratumumab Hyaluronida 1800Mg
Gross
$45,300
J3055
$41,971
Talquetamab-Tgvs 40 Mg/Ml Vial
Gross
$43,268
J3055
$41,971
Talquetamab-Tgvs 40 Mg/Ml Vial
Gross
$43,268
J1930
$41,884
Lanreotide Acet 120MG/0.5ML Sy
Gross
$43,179
J1930
$41,884
Lanreotide Acet 120MG/0.5ML Sy
Gross
$43,179
J9380
$39,173
Teclistamab-Cqyv 153 Mg/1.7 Ml
Gross
$40,384
J9380
$39,173
Teclistamab-Cqyv 153 Mg/1.7 Ml
Gross
$40,384
J3380
$39,132
Vedolizumab 300 MG Vial
Gross
$40,342
J3380
$39,132
Vedolizumab 300 MG Vial
Gross
$40,342
J9228
$37,986
Ipilimumab 5 MG/ML 10 ML Vial
Gross
$39,160
J9228
$37,986
Ipilimumab 5 MG/ML 10 ML Vial
Gross
$39,160
J9301
$36,267
Obinutuzumab 1000 MG/40ML Vial
Gross
$37,388
J9301
$36,267
Obinutuzumab 1000 MG/40ML Vial
Gross
$37,388
J2323
$35,979
Natalizumab 300 MG/15 ML Vial
Gross
$37,092
J2323
$35,979
Natalizumab 300 MG/15 ML Vial
Gross
$37,092
J9223
$34,847
Lurbinectedin 0.1 Mg
Gross
$35,925
J9223
$34,847
Lurbinectedin 0.1 Mg
Gross
$35,925
J3101
$30,637
Tenecteplase 50 Mg/10 Ml Syrng
Gross
$31,584
J3101
$30,637
Tenecteplase 50 Mg/10 Ml Syrng
Gross
$31,584
J1299
$29,933
Eculizumab 300 MG/30 ML Vial
Gross
$30,858
J1299
$29,933
Eculizumab 300 MG/30 ML Vial
Gross
$30,858
J9063
$28,369
Mirvetuximab Soravtansine-Gynx
Gross
$29,246
J9063
$28,369
Mirvetuximab Soravtansine-Gynx
Gross
$29,246
J9271
$25,641
Pembrolizumab 100 MG/4 ML Vial
Gross
$26,434
J9271
$25,641
Pembrolizumab 100 MG/4 ML Vial
Gross
$26,434
J0717
$25,110
Certolizumab Pegol 400 Mg Kit
Gross
$25,886
J0717
$25,110
Certolizumab Pegol 400 Mg Kit
Gross
$25,886
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J9347 | Tremelimumab-Actl 300 Mg/15 Ml | $175,800 | $170,526 | — | — | 3 |
| J9347 | Tremelimumab-Actl 300 Mg/15 Ml | $175,800 | $170,526 | — | — | 6 |
| J2350 | Ocrelizumab 300 Mg/10 Ml | $89,025 | $86,355 | — | — | 3 |
| J2350 | Ocrelizumab 300 Mg/10 Ml | $89,025 | $86,355 | — | — | 8 |
| J9309 | Polatuzumab Ved-Piiq 140 Mg Vl | $81,611 | $79,164 | — | — | 3 |
| J9309 | Polatuzumab Ved-Piiq 140 Mg Vl | $81,611 | $79,164 | — | — | 6 |
| J9026 | Tarlatamab-DLLE 10 Mg Vial | $67,650 | $65,621 | — | — | 3 |
| J9026 | Tarlatamab-DLLE 10 Mg Vial | $67,650 | $65,621 | — | — | 7 |
| J9298 | Nivolum/Relatlim 240-80Mg 113G | $66,652 | $64,653 | — | — | 3 |
| J9298 | Nivolum/Relatlim 240-80Mg 113G | $66,652 | $64,653 | — | — | 6 |
| J9043 | Cabazitaxel 60 MG/1.5 ML Vial | $63,665 | $61,756 | — | — | 3 |
| J9043 | Cabazitaxel 60 MG/1.5 ML Vial | $63,665 | $61,756 | — | — | 6 |
| J9316 | Pertuzu-Trastuzu 15 Ml Vial | $59,562 | $57,775 | — | — | 3 |
| J9316 | Pertuzu-Trastuzu 15 Ml Vial | $59,562 | $57,775 | — | — | 7 |
| J9272 | Dostarlimab-Gxly 500 Mg/10 Ml | $53,106 | $51,513 | — | — | 3 |
| J9272 | Dostarlimab-Gxly 500 Mg/10 Ml | $53,106 | $51,513 | — | — | 6 |
| J9042 | Brentuximab Vedotin 50 MG Vial | $52,989 | $51,399 | — | — | 3 |
| J9042 | Brentuximab Vedotin 50 MG Vial | $52,989 | $51,399 | — | — | 6 |
| J9022 | Atezolizumab 1200 Mg/20 Ml Vl | $49,033 | $47,562 | — | — | 3 |
| J9022 | Atezolizumab 1200 Mg/20 Ml Vl | $49,033 | $47,562 | — | — | 6 |
| J9119 | Cemiplimab-Rwlc 350 Mg/7 Ml Vl | $46,640 | $45,241 | — | — | 3 |
| J9119 | Cemiplimab-Rwlc 350 Mg/7 Ml Vl | $46,640 | $45,241 | — | — | 6 |
| J9144 | Daratumumab Hyaluronida 1800Mg | $45,300 | $43,942 | — | — | 3 |
| J9144 | Daratumumab Hyaluronida 1800Mg | $45,300 | $43,942 | — | — | 6 |
| J3055 | Talquetamab-Tgvs 40 Mg/Ml Vial | $43,268 | $41,971 | — | — | 3 |
| J3055 | Talquetamab-Tgvs 40 Mg/Ml Vial | $43,268 | $41,971 | — | — | 6 |
| J1930 | Lanreotide Acet 120MG/0.5ML Sy | $43,179 | $41,884 | — | — | 3 |
| J1930 | Lanreotide Acet 120MG/0.5ML Sy | $43,179 | $41,884 | — | — | 6 |
| J9380 | Teclistamab-Cqyv 153 Mg/1.7 Ml | $40,384 | $39,173 | — | — | 3 |
| J9380 | Teclistamab-Cqyv 153 Mg/1.7 Ml | $40,384 | $39,173 | — | — | 6 |
| J3380 | Vedolizumab 300 MG Vial | $40,342 | $39,132 | — | — | 3 |
| J3380 | Vedolizumab 300 MG Vial | $40,342 | $39,132 | — | — | 9 |
| J9228 | Ipilimumab 5 MG/ML 10 ML Vial | $39,160 | $37,986 | — | — | 3 |
| J9228 | Ipilimumab 5 MG/ML 10 ML Vial | $39,160 | $37,986 | — | — | 6 |
| J9301 | Obinutuzumab 1000 MG/40ML Vial | $37,388 | $36,267 | — | — | 3 |
| J9301 | Obinutuzumab 1000 MG/40ML Vial | $37,388 | $36,267 | — | — | 10 |
| J2323 | Natalizumab 300 MG/15 ML Vial | $37,092 | $35,979 | — | — | 3 |
| J2323 | Natalizumab 300 MG/15 ML Vial | $37,092 | $35,979 | — | — | 6 |
| J9223 | Lurbinectedin 0.1 Mg | $35,925 | $34,847 | — | — | 3 |
| J9223 | Lurbinectedin 0.1 Mg | $35,925 | $34,847 | — | — | 6 |
| J3101 | Tenecteplase 50 Mg/10 Ml Syrng | $31,584 | $30,637 | — | — | 3 |
| J3101 | Tenecteplase 50 Mg/10 Ml Syrng | $31,584 | $30,637 | — | — | 6 |
| J1299 | Eculizumab 300 MG/30 ML Vial | $30,858 | $29,933 | — | — | 3 |
| J1299 | Eculizumab 300 MG/30 ML Vial | $30,858 | $29,933 | — | — | 6 |
| J9063 | Mirvetuximab Soravtansine-Gynx | $29,246 | $28,369 | — | — | 3 |
| J9063 | Mirvetuximab Soravtansine-Gynx | $29,246 | $28,369 | — | — | 6 |
| J9271 | Pembrolizumab 100 MG/4 ML Vial | $26,434 | $25,641 | — | — | 3 |
| J9271 | Pembrolizumab 100 MG/4 ML Vial | $26,434 | $25,641 | — | — | 10 |
| J0717 | Certolizumab Pegol 400 Mg Kit | $25,886 | $25,110 | — | — | 3 |
| J0717 | Certolizumab Pegol 400 Mg Kit | $25,886 | $25,110 | — | — | 6 |
Showing top 50 of 6,287 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.